However, the results showed that the STK17B expression were not significantly associated with other parameters, including N, M stage, pathologic stage, melanoma Clark level, melanoma ulceration, gender, race, tumor tissue site, BRAF status and age (all P > 0.05). This evidence concerns the gene BRAF and melanoma.